This issue features a look at new tactics for fighting the cancer drug pricing bloat, a debate on fludarabine in CLL, a report from ASH’s Sickle Cell Disease Summit, and more.
This issue features a look at the ACA’s out-of-pocket limit, reports from the IOM’s Pediatric Oncology Workshop, tips for improving your presentations, and more.
This issue features a debate of rituximab versus splenectomy in ITP patients, a look at novel oral anticoagulants taking warfarin’s place, mentoring advice from a fellowship program director, and more.
This issue features ABIM's update to MOC, the endocrinologist's perspective on diabetes management, an analysis of the Choosing Wisely program, and more.
A special edition featuring drug updates from the 2014 ASH Annual Meeting.
This issue features breakthrough research from the 2014 ASH Annual Meeting, a look at changing definitions of value, a debate over transplant in AML patients, and more.
This issue features an update from the ASH Choosing Wisely Task Force, a look at the first wave of Sunshine Act data, a debate over radiation therapy in Hodgkin lymphoma, and more.
This issue features essential information for clinical practice, education, and research.